Applied Genetic Tech (AGTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,978 | 26,472 | 31,065 | 47,633 | 70,345 |
| Marketable Securities | 72,097 | 78,968 | 73,840 | 64,167 | 49,312 |
| Receivables | 116 | 219 | 210 | 133 | 203 |
| Other current assets | 0 | 2,527 | 0 | 3,968 | 0 |
| TOTAL | $99,150 | $108,186 | $109,124 | $115,901 | $123,872 |
| Non-Current Assets | |||||
| PPE Net | 4,778 | 5,016 | 5,254 | 5,526 | 3,235 |
| Investments And Advances | 1,961 | 1,972 | 1,980 | 1,995 | 2,000 |
| Intangibles | 954 | 949 | 968 | 0 | 0 |
| Other Non-Current Assets | 1,260 | 1,205 | 1,206 | 2,025 | 2,226 |
| TOTAL | $8,953 | $9,142 | $9,408 | $9,546 | $7,461 |
| Total Assets | $108,103 | $117,328 | $118,532 | $125,447 | $131,333 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,664 | 3,029 | 945 | 1,322 | 1,036 |
| Accrued Expenses | 5,823 | 5,677 | 7,155 | 8,035 | 6,116 |
| TOTAL | $20,188 | $25,025 | $14,395 | $17,545 | $19,097 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 12,701 | 16,319 | 6,295 | 8,188 | 11,945 |
| Other Non-Current Liabilities | 4,209 | 4,258 | 4,345 | 2,294 | 653 |
| TOTAL | $11,940 | $13,364 | $4,955 | $3,206 | $653 |
| Total Liabilities | $32,128 | $38,389 | $19,350 | $20,751 | $19,750 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18,165 | 18,134 | 18,129 | 18,111 | 18,105 |
| Common Shares | 18 | 18 | 18 | 18 | 18 |
| Retained earnings | -136,523 | -132,342 | -110,926 | -104,314 | -96,213 |
| Other shareholders' equity | -70 | -57 | -49 | -23 | 0 |
| TOTAL | $75,975 | $78,939 | $99,182 | $104,696 | $111,583 |
| Total Liabilities And Equity | $108,103 | $117,328 | $118,532 | $125,447 | $131,333 |